Molecular determinants of response to high-dose androgen therapy in prostate cancer. [electronic resource]
Producer: 20201013ISSN:- 2379-3708
- Androgens -- pharmacology
- CRISPR-Cas Systems
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockout Techniques
- Genes, p53 -- genetics
- Humans
- Male
- Prostatic Neoplasms -- drug therapy
- Retinoblastoma Binding Proteins -- genetics
- Ubiquitin-Protein Ligases -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.